By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Inotek Pharmaceuticals Corporation 

100 Cummings Center
Suite 419E
Beverly  Massachusetts  01915  U.S.A.
Phone: 978-232-9660 Fax: 978-232-8975


SEARCH JOBS


Industry
Pharmaceutical






Company News
Inotek Pharmaceuticals Corporation (ITEK) Expands Intellectual Property Portfolio With Combination Patent 7/22/2016 9:04:48 AM
Inotek Pharmaceuticals Corporation (ITEK) Initiates Phase 2 Dose-ranging Trial Of A Fixed-Dose Combination Of Trabodenoson, A Novel Treatment For Glaucoma, And Latanoprost 7/13/2016 10:43:32 AM
Inotek Pharmaceuticals Corporation (ITEK) To Present At Upcoming Investor Conferences 7/8/2016 9:29:17 AM
Inotek Pharmaceuticals Corporation (ITEK) Announces Participation In Fireside Chat At JMP Securities 2016 Life Sciences Conference 6/16/2016 10:21:49 AM
Inotek Pharmaceuticals Corporation (ITEK) Reports First Quarter 2016 Financial Results and Operational Highlights 5/11/2016 10:51:28 AM
Inotek Pharmaceuticals Corporation (ITEK) Announces Poster Presentations On Trabodenoson At The Association for Research in Vision & Ophthalmology 2016 Annual Meeting 4/26/2016 12:02:05 PM
Inotek Pharmaceuticals Corporation (ITEK) Announces The Journal Of Ocular Pharmacology And Therapeutics Has Published Its Phase 2 Data For Trabodenoson In Patients With Glaucoma And Ocular Hypertension 4/11/2016 12:12:32 PM
Inotek Pharmaceuticals Corporation (ITEK) Announces Changes To Board Of Directors 4/5/2016 8:43:10 AM
Inotek Pharmaceuticals Corporation (ITEK) Reports Fiscal Year 2015 Financial Results And Operational Highlights 3/23/2016 9:10:56 AM
Inotek Pharmaceuticals Corporation (ITEK) To Present At GTCBIO’s 8th Ocular Diseases And Drug Discovery Conference 3/14/2016 9:08:10 AM
123456789
//-->